Close Menu

In Newsweek, Sharon Begley writes that "second thoughts" about personalized medicine "are clearly setting in" as a result of studies showing that adding genetic risk factors to traditional risk factors does not improve the ability to predict whether someone develops that disease. "The revolution in using DNA to read people's medical future is turning out to be more hype than hope," Begley writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.